FTC Declares Victory in Generic Drug Case

FTC Declares Victory in Generic Drug Case Play

June 17 (Bloomberg) -- Drugmakers can be sued for paying rivals to delay low-cost versions of popular medicines, the U.S. Supreme Court said in a decision that rewrites the rules governing the release of generic drugs. Olivia Sterns reports on Bloomberg Television's "Bottom Line." (Source: Bloomberg)

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus